Age Moderates the Impact of TRAbs on Thyroid Hormones and Hepatic Function in Patients with Graves' Disease

被引:2
|
作者
Guo, Kai [1 ]
Ling, Hongwei [2 ]
Zhou, Xiaoyan [1 ]
Ying, Changjiang [2 ]
机构
[1] Xuzhou Med Univ, Grad Sch, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Endocrinol, Affiliated Hosp, 99 West Huai Hai Rd, Xuzhou 221000, Jiangsu, Peoples R China
基金
俄罗斯科学基金会;
关键词
Graves' disease; thyrotropin receptor antibodies; thyroid hormone; hepatic function; LIVER-FUNCTION TESTS; THYROTROPIN RECEPTOR; INCREASED MORTALITY; SERIAL CHANGES; HYPERTHYROIDISM; DYSFUNCTION; MITOCHONDRIA; PREVALENCE; MANAGEMENT; DIAGNOSIS;
D O I
10.1055/a-1510-9100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyrotropin receptor antibodies (TRAbs) play a significant role in the course of hepatic dysfunction (HDF) in patients with Graves' disease (GD). However, few studies have considered the factors that influence the relationships among TRAbs, thyroid hormone levels, and hepatic function in subjects with newly diagnosed GD. Here we investigated the associations of TRAbs with thyroid hormones and hepatic function and assessed potential factors that can influence these associations among patients with GD. A total of 368 patients newly diagnosed with GD were collected in this cross-sectional study. Patients who had received antithyroid drugs, radioactive iodine, or surgery were excluded. Levels of TRAbs and thyroid hormones and hepatic function were recorded. Linear and binary logistic regression analysis models were applied to investigate associations among these variables after adjusting for confounding characteristics. There was a significant difference in TRAbs indices between the HDF and normal hepatic function groups (p <0.05). After adjusting for confounders, the relationship between TRAbs and thyroid hormones was nonlinear, showing a curve with an initial positive slope and a subsequent flattening (p <0.05). Higher TRAbs were associated with HDF [odds ratio (OR) 1.036, 95% confidence interval (CI) 1.018-1.053 per 1-IU/l increase]. These associations were modified by age, but not by gender, smoking status, Graves' orbitopathy, thyroid-peroxidase antibody levels, or thyroglobulin antibody levels. In younger patients, increasing TRAbs were correlated with higher thyroid hormones and HDF (OR 1.034, 95% CI 1.017-1.052) per1-IU/l increase). In older patients, TRAbs were not correlated with thyroid hormones or HDF (OR 1.024, 95% CI 0.993-1.056) per 1-IU/l increase. Age can affect the impact of TRAbs on thyroid hormone levels and hepatic function in GD. TRAb measurement can have good predictive value in younger patients.
引用
收藏
页码:453 / 460
页数:8
相关论文
共 50 条
  • [21] Incidental thyroid carcinoma in patients with Graves' disease
    Phitayakorn, Roy
    McHenry, Christopher R.
    AMERICAN JOURNAL OF SURGERY, 2008, 195 (03) : 292 - 297
  • [22] Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease
    Nagasaki, Toshiki
    Inaba, Masaaki
    Fujiwara-Ueda, Misako
    Nishio, Junko
    Kumeda, Yasuro
    Hiura, Yoshikazu
    Tahara, Hideki
    Ishimura, Eiji
    Ishiko, Osamu
    Nishizawa, Yoshiki
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (02) : 113 - 117
  • [23] Premature twins of a mother with Graves' disease with discordant thyroid function: a case report
    O'Connor, M. J.
    Paget-Brown, A. O.
    Clarke, W. L.
    JOURNAL OF PERINATOLOGY, 2007, 27 (06) : 388 - 389
  • [24] Premature twins of a mother with Graves' disease with discordant thyroid function: a case report
    M J O'Connor
    A O Paget-Brown
    W L Clarke
    Journal of Perinatology, 2007, 27 : 388 - 389
  • [25] The impact of thyroid hormones on patients with hepatocellular carcinoma
    Pinter, Matthias
    Haupt, Lukas
    Hucke, Florian
    Bota, Simona
    Bucsics, Theresa
    Trauner, Michael
    Peck-Radosavljevic, Markus
    Sieghart, Wolfgang
    PLOS ONE, 2017, 12 (08):
  • [26] Serum Selenium Levels in Patients With Graves Disease With or Without Thyroid Ophthalmopathy
    Owji, Naser
    Moradi, Fatemeh
    Khalili, Mohammad Reza
    Jahanbani-Ardakani, Hamidreza
    ENDOCRINE PRACTICE, 2022, 28 (12) : 1216 - 1220
  • [27] THYROID-HORMONE AUTOANTIBODIES IN PATIENTS WITH UNTREATED GRAVES-DISEASE - WITH SPECIAL REFERENCE TO AGE
    NAKAMURA, S
    HATTORI, J
    OGAWA, T
    SAKATA, S
    ENDOCRINE JOURNAL, 1993, 40 (03) : 337 - 342
  • [28] Fetal and neonatal thyroid function in relation to maternal Graves' disease
    Polak, M
    Le Gac, I
    Vuillard, E
    Guibourdenche, J
    Leger, J
    Toubert, ME
    Madec, AM
    Oury, JF
    Czernichow, P
    Luton, D
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (02) : 289 - 302
  • [29] A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease
    Taprogge, Jan
    Gape, Paul M. D.
    Carnegie-Peake, Lily
    Murray, Iain
    Gear, Jonathan, I
    Leek, Francesca
    Hyer, Steve L.
    Flux, Glenn D.
    THYROID, 2021, 31 (12) : 1829 - 1838
  • [30] Predictive Factors of Thyroid Cancer in Patients with Graves' Disease
    Ren, Meng
    Wu, Mu Chao
    Shang, Chang Zhen
    Wang, Xiao Yi
    Zhang, Jing Lu
    Cheng, Hua
    Xu, Ming Tong
    Yan, Li
    WORLD JOURNAL OF SURGERY, 2014, 38 (01) : 80 - 87